Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET Ā | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…
RadioMedix Debuts Proprietary bench top Pb Generator to Support Targeted Alpha Therapy Development
New bench top Ā²Ā¹Ā²Pb generator to expand clinical-grade isotope supply for targeted…
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
June 11, 2025 11:30 ET Ā | Source: Onconetix, Inc. CINCINNATI, Ohio, June…
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic…
Sesen Launches with a Singular Mission: Advancing Life Sciences Globally Through Specialized Language Solutions
BOSTON--(BUSINESS WIRE)--Today marks the official launch of Sesen, a next-generation language services…
RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
June 06, 2025 16:07 ET Ā | Source: Restem MIAMI, June 06, 2025…
ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)
June 05, 2025 16:31 ET Ā | Source: ImPact Biotech āĀ Previously inoperable…
Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development
June 02, 2025 04:00 ET Ā | Source: Aravax MELBOURNE, Australia and OXFORD,…
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd (āAvistoneā), an innovative biotechnology company focused…